Schedule 13G ownership disclosure
Denali Therapeutics Inc
Security class unavailable · CUSIP: 24823R105
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 15,119,474
- Percent of class
- 11.1300%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001088875-23-000042
- Form type
- SC 13G
- Filer
- BAILLIE GIFFORD & CO
- CIK
- CIK 1088875
- Filed
- Jan 20, 2023
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership